Form 4 Filing for Joseph Vazzano

This Form 4 filing details a transaction by Joseph Vazzano, Chief Financial Officer of Abeona Therapeutics Inc. On March 16, 2026, Mr. Vazzano disposed of 785 shares of Common Stock at a price of $4.76 per share. This sale was conducted to cover tax obligations arising from the vesting of restricted stock awards. Following this transaction, Mr. Vazzano directly owns 567,775 shares of Abeona Therapeutics Inc. common stock.